Research Posters
Real-Time Continuous Glucose Monitoring For Patients with Type 2 Diabetes
In a database study, AMGA examined the effects of real-time continuous glucose monitoring (CGM) on 458 primary care patients with type 2 diabetes. Patients with a CGM and an HbA1c above 7.5 percent saw an average of -0.9 percent change in their blood glucose regardless of the medication therapy regimen.
Contact: sshields@amga.org
Using EHR Data to Identify Chronic Opioid Use in Patients with Osteoarthritis
AMGA developed a chronic opioid use definition using electronic health record (EHR) data. Using EHR data to identify the risk of chronic opioid use could facilitate clinical decision-making at the point of care when considering pain treatment options. The definition may also be used for quality improvement and research.
Contact: jmohl@amga.org
Jeff Mohl, Ph.D., Director of Research and Analytics presents on EHR data model on chronic opioid use at the American Medical Informatics Association (AMIA) in May 2022
Trends in Follow-up Colonoscopy following a Positive Stool-based Screening Test for Colorectal Cancer
An assessment of follow-up colonoscopy rates after a positive stool-based test found over 40 percent of patients fail to receive appropriate follow-up. Disparities exist by race, insurance type and by test modality (FIT or mt-sDNA).
Contact: jmohl@amga.org
Impact of COVID-19 on Follow-up Colonoscopy Rates After a Positive Stool-based Screening Test for Colorectal Cancer
Follow-up colonoscopy rates after a positive stool-based screening test (SBT) for colorectal cancer declined sharply during the COVID-19 pandemic. The decrease in the accessibility of colonoscopies may have created a care gap for some patients, especially for those who with a positive SBT at the start of the pandemic (March 2020).
Contact: agillen@amga.org
AMGA Lead Population Health Analyst Abbie Gillen presents the impact of COVID-19 on follow-up colonoscopy rates at Academy Health’s Annual Research Meeting, June 2022
Impact of COVID-19 on Diabetes Care
This study describes changes in routine care for patients with type 2 diabetes (T2DM) among AMGA member health care organizations (HCOs) during COVID-19. In Jan/Feb 2020 fewer than 1% of visits were conducted via telehealth (range 0–3%) increasing to 64% by April (range 13–90%). Home testing/monitoring of HbA1c and drive-thru clinics may explain why some HCOs seemed better equipped to test and monitor patients. Patients with A1c levels >9 had fewer visits. Black patients had smaller declines in visits and greater use of telehealth. Asian patients had the largest decrease of in-person visits.
Contact: crattelman@amga.org
Strategies to Improve Care for People with Obesity
Results of a three-year, population health focused, obesity care model learning collaborative in which 10 U.S. health care organizations implemented strategies within primary care practices that improved care for patients with obesity.
Contact: eciemins@amga.org
